Commission lawsuit violations committed by agents can now be caught in real-time by AI-fueled MLS technologies. Compliance ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

Initially, the Q7 will debut solely with petrol power with the TFSI V6 being joined in January by the now petrol-powered SQ7.

There are no changes to the cost of the Everest Ambiente and Trend – or any option packs – for 2025, while the Sport has ...

Moreover, we managed to do this within just four months of FDA approval, demonstrating our operational agility ... First, let's discuss our AVITA Medical branded collagen-based dermal matrix that we ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

BEAD is anticipated to significantly boost Dycom's revenue and margin growth from FY 2026, with a peak organic growth ...

pricing, uncertainties associated with the development and process for obtaining regulatory approval for new products, the ability to consummate and integrate acquisitions, and other risks, ...

Amtagvi Infusions: A total of 146 patients have been infused with Amtagvi since the first commercial infusion in April 2024, including 25 patients infused in the second quarter, 82 patients infused in ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

GPO Access: Advanced discussions with major group purchasing organizations (GPOs), including private health systems and the Veterans Administration (VA), with favorable coverage decisions anticipated ...

Cango Inc. (NYSE: CANG ) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that it has entered into agreements to purchase on-rack crypto mining ...